Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122108) titled 'Clinical study of tigelilidine for patient-controlled intravenous analgesia combined with adductor canal block after knee arthroplasty' on April 9.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Jingzhou Hospital Affiliated to Yangtze University
Condition:
Analgesia after knee arthroplasty
Intervention:
Group S:Group S: sufentanil 2ug/kg+ dolasetron 0.4mg, diluted to 100ml of normal saline
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-04-20
Target Sample Size: Group S:43;Group T:43;
Countries of Recruitment:
China
To know more, visit https:/...